Galectin-3 Positive Cells
Galectin-3 Positive Cells - Related Videos
08:48
Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads
0 Views •
2020
This article describes the experimental procedures for (a) depletion of U1 snRNP from nuclear extracts, with concomitant loss of splicing activity; and (b) reconstitution of splicing activity in the U1-depleted extract by galectin-3 - U1 snRNP particles bound to beads covalently coupled with anti-galectin-3 antibodies.
08:30
Monovalent Cation Doping of CH3NH3PbI3 for Efficient Perovskite Solar Cells
0 Views •
Cited by 31 •
2017
Here, we present a protocol to adjust the properties of solution-processed CH3NH3PbI3 through the incorporation of monovalent cation additives in order to achieve highly efficient perovskite solar cells.
12:19
Analysis of Cell Cycle Position in Mammalian Cells
0 Views •
Cited by 71 •
2012
Determining the cell cycle position of a population of cells, or understanding how signals affect proliferation, can be readily measured by flow cytometry using this protocol. We report a simple experimental approach to staining cells and quantifying their position in the cell cycle.
02:32
Position-effect Variegation
0 Views •
2020
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
04:41
Magnetic-Activated Cell Sorting: A Method to Isolate c-Kit Positive Cells
0 Views •
2023
This video describes the technique of isolating c-kit positive cells from the bone marrow of a mouse. In the protocol, we will isolate c-kit positive cells from a transgenic mouse to validate c-Fos and Dusp1 alone or together as drug targets in leukemia.
FAQs
Galectin-3-positive cells can be interpreted through two linked signaling locations. Inside cells, galectin-3 contributes to cellular signaling, while outside cells it binds glycans on receptors and extracellular-matrix components. These interactions can alter adhesion and migration and can also promote immune activation or fibrotic signaling. Therefore, positivity may reflect several biological processes rather than one uniform cellular behavior.
Galectin-3 positivity does not by itself identify a single disease process. In tumors, inflamed tissues, and damaged organs, the same detectable signal may be associated with different tissue responses. Interpreting it alongside location, tissue condition, and assay specificity helps distinguish a meaningful biological pattern from an overly broad conclusion about disease.
Extracellular galectin-3 can bind glycans on receptors and extracellular-matrix components, linking galectin-3 expression with changes in cell communication and tissue organization. These interactions may influence immune activation, cell adhesion, migration, and fibrotic signaling. Consequently, detecting positive cells can help investigators examine how cellular responses connect with inflammation or tissue remodeling in disease.
Immunostaining helps identify galectin-3-associated signal in tissue and map where positive cells occur within tumors, inflamed tissues, or damaged organs. Its value comes from preserving the tissue setting, allowing expression to be considered alongside local pathology. Because interpretation depends on assay specificity, staining results should be evaluated in context rather than treated as an isolated finding.
These approaches provide different views of galectin-3 expression. Immunostaining helps map signal within tissue, whereas flow cytometry can identify galectin-3-positive cell populations for comparative analysis. Gene and protein assays add expression-level information. Using these methods together can strengthen characterization of a tissue response, while also revealing whether conclusions are consistent across measurement types.
Mapping galectin-3-positive cells can support investigations of disease mechanisms in tumors, inflamed tissues, and damaged organs. The resulting expression patterns may contribute to biomarker development and prognosis research, and they can inform studies of therapies directed at galectin-3-associated pathways. Such uses remain dependent on tissue context and on the specificity of the detection method.